ARCHIVES

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Evaluating PDQ Evaluation

September 1, 1989

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

January 10, 1997